Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Newron raises CHF4.7m through a Private Placement

Newron Pharmaceuticals S.p.A.
Posted on: 21 Aug 12

Milan, Italy – 20 August, 2012 – Newron Pharmaceuticals S.p.A. (“Newron”, SIX: NWRN), a research and development company focused on Central Nervous System (CNS) and pain therapies, today announced that it has successfully raised funds of approximately CHF4.7m (EUR3.9m) through a private placement. In total, 798,945 immediately tradeable shares were placed with new and existing institutional investors.

Stefan Weber, Newron’s CEO, said: “We are delighted to have the support of a strong group of international institutional investors. This is an exciting time for Newron as we look forward to regulatory submission for safinamide and focus on the next priorities in our innovative CNS pipeline.”

For more information:

Editor's Details

Stephanie Cuthbert
F T I Consulting

Last updated on: 21/08/2012

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.